Advisor Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Advisor Group's EW Position: Q4 2019 in Review
Advisor Group increased its Edwards Lifesciences (EW) stake by 2.2% in Q4 2019, buying an estimated $95.1K and bringing the position to 56,739 shares worth $4.41M. The position accounts for 0.03% of the portfolio, ranked #452.
Advisor Group first reported a position in EW in Q2 2016 and has held it in 15 quarters since. The position peaked at $4.66M in Q1 2019. 1,093 funds tracked by Wall St. Rank hold EW as of Q4 2019.
- Advisor Group held 56,739 shares of Edwards Lifesciences worth $4.41M as of Q4 2019.
- Advisor Group bought 1,218 Edwards Lifesciences shares in Q4 2019, an estimated $95.1K.
- Edwards Lifesciences made up 0.03% of Advisor Group's portfolio in Q4 2019, its #452 holding.
- Advisor Group first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 15 quarters since.
- Advisor Group's Edwards Lifesciences position peaked at $4.66M in Q1 2019.
- 1,093 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.